The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma
Interleukin (IL)-31A binds to an heterodimer composed of IL-31 receptor A (IL-31RA) and Oncostatin M Receptor (OSMR). The IL-31/IL-31R complex is involved in the pathogenesis of various skin diseases, including cutaneous T-cell lymphoma. No information is available on the relations between the IL-31/IL-31R complex and B-cell lymphoma. Here we have addressed this issue in follicular lymphoma (FL), a prototypic germinal center(GC)-derived B-cell malignancy. IL-31 enhanced primary FL cell proliferation through IL-31R-driven signal transducer and activator of transcription factor 1/3 (STAT1/3), extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt phosphorylation. In contrast, GC B cells did not signal to IL-31 in spite of IL-31R expression. GC B cells expressed predominantly the inhibitory short IL-31RA isoform, whereas FL cells expressed predominantly the long signaling isoform. Moreover, GC B cells lacked expression of other IL-31RA isoforms potentially involved in the signaling pathway. IL-31 protein expression was significantly higher in surface membrane than in cytosol of both FL and GC B cells. IL-31 was detected in plasma membrane microvesicles from both cell types but not released in soluble form in culture supernatants. IL-31 and IL-31RA expression was higher in lymph nodes from FL patients with grade IIIa compared with grade I/II, suggesting a paracrine and/or autocrine role of IL-31/IL-31RA complex in tumor progression through microvesicle shedding..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Leukemia - 29(2015), 4, Seite 958-967 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ferretti, E [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1038/leu.2014.291 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1957618191 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1957618191 | ||
| 003 | DE-627 | ||
| 005 | 20230714143355.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1038/leu.2014.291 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1957618191 | ||
| 035 | |a (DE-599)GBVOLC1957618191 | ||
| 035 | |a (PRQ)c2004-f887ec328961d5004cb45b5dad674c80fd2ee832ec7054ef101c2bf3cc39c2560 | ||
| 035 | |a (KEY)0157628320150000029000400958interleukinil31il31raxiscontributestotumorgrowthin | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 100 | 1 | |a Ferretti, E |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a Interleukin (IL)-31A binds to an heterodimer composed of IL-31 receptor A (IL-31RA) and Oncostatin M Receptor (OSMR). The IL-31/IL-31R complex is involved in the pathogenesis of various skin diseases, including cutaneous T-cell lymphoma. No information is available on the relations between the IL-31/IL-31R complex and B-cell lymphoma. Here we have addressed this issue in follicular lymphoma (FL), a prototypic germinal center(GC)-derived B-cell malignancy. IL-31 enhanced primary FL cell proliferation through IL-31R-driven signal transducer and activator of transcription factor 1/3 (STAT1/3), extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt phosphorylation. In contrast, GC B cells did not signal to IL-31 in spite of IL-31R expression. GC B cells expressed predominantly the inhibitory short IL-31RA isoform, whereas FL cells expressed predominantly the long signaling isoform. Moreover, GC B cells lacked expression of other IL-31RA isoforms potentially involved in the signaling pathway. IL-31 protein expression was significantly higher in surface membrane than in cytosol of both FL and GC B cells. IL-31 was detected in plasma membrane microvesicles from both cell types but not released in soluble form in culture supernatants. IL-31 and IL-31RA expression was higher in lymph nodes from FL patients with grade IIIa compared with grade I/II, suggesting a paracrine and/or autocrine role of IL-31/IL-31RA complex in tumor progression through microvesicle shedding. | ||
| 650 | 4 | |a Cytosol - metabolism | |
| 650 | 4 | |a STAT1 Transcription Factor - metabolism | |
| 650 | 4 | |a Germinal Center - metabolism | |
| 650 | 4 | |a STAT3 Transcription Factor - genetics | |
| 650 | 4 | |a Protein Isoforms - genetics | |
| 650 | 4 | |a Mitogen-Activated Protein Kinase 1 - genetics | |
| 650 | 4 | |a Mitogen-Activated Protein Kinase 1 - metabolism | |
| 650 | 4 | |a B-Lymphocytes - pathology | |
| 650 | 4 | |a Receptors, Interleukin - metabolism | |
| 650 | 4 | |a STAT1 Transcription Factor - genetics | |
| 650 | 4 | |a Lymphoma, Follicular - genetics | |
| 650 | 4 | |a Mitogen-Activated Protein Kinase 3 - genetics | |
| 650 | 4 | |a Lymphoma, Follicular - metabolism | |
| 650 | 4 | |a Germinal Center - pathology | |
| 650 | 4 | |a Protein Isoforms - metabolism | |
| 650 | 4 | |a Receptors, Interleukin - genetics | |
| 650 | 4 | |a Proto-Oncogene Proteins c-akt - genetics | |
| 650 | 4 | |a STAT3 Transcription Factor - metabolism | |
| 650 | 4 | |a Cell Membrane - metabolism | |
| 650 | 4 | |a Lymphoma, Follicular - pathology | |
| 650 | 4 | |a B-Lymphocytes - metabolism | |
| 650 | 4 | |a Proto-Oncogene Proteins c-akt - metabolism | |
| 650 | 4 | |a Mitogen-Activated Protein Kinase 3 - metabolism | |
| 650 | 4 | |a Interleukins - genetics | |
| 650 | 4 | |a Cell-Derived Microparticles - metabolism | |
| 650 | 4 | |a Interleukins - metabolism | |
| 700 | 1 | |a Tripodo, C |4 oth | |
| 700 | 1 | |a Pagnan, G |4 oth | |
| 700 | 1 | |a Guarnotta, C |4 oth | |
| 700 | 1 | |a Marimpietri, D |4 oth | |
| 700 | 1 | |a Corrias, M V |4 oth | |
| 700 | 1 | |a Ribatti, D |4 oth | |
| 700 | 1 | |a Zupo, S |4 oth | |
| 700 | 1 | |a Fraternali-Orcioni, G |4 oth | |
| 700 | 1 | |a Ravetti, J L |4 oth | |
| 700 | 1 | |a Pistoia, V |4 oth | |
| 700 | 1 | |a Corcione, A |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1987 |g 29(2015), 4, Seite 958-967 |w (DE-627)168701375 |w (DE-600)807030-1 |w (DE-576)016193326 |x 0887-6924 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2015 |g number:4 |g pages:958-967 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1038/leu.2014.291 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25283844 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1672072654 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4219 | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2015 |e 4 |h 958-967 | ||